AAM Warns Over Biden Budget Plans To Extend IRA
Announcement Adds To Uncertainty For US Off-Patent Drug Development
US generics and biosimilars association the AAM has offered a frosty response to budget plans announced by the Biden administration that include expanding the scope of price negotiation under the Inflation Reduction Act.
